UPDATE 1-Lexicon Pharma diabetes drug shows promise; shares up
Jan 6 (Reuters) - Lexicon Pharmaceuticals Inc said a mid-stage study of an oral dose of its type-2 diabetes drug showed promise compared to the liquid version, sending its shares up 45 percent in trading before the bell.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here